These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8778949)

  • 21. [Nonspecific immunity factors and elimination of circulating immune complexes in patients with myocardial infarct in the 1st phase of rehabilitation].
    Chan G; Osipov SG; Sipatova MA; Soboleva VA; Nikitin AE
    Kardiologiia; 1985 Aug; 25(8):35-7. PubMed ID: 4068457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
    Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
    Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease.
    Örem A; Yayli S; Arıca DA; Akcan B; Yücesan FB; Bahadir S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kawasaki disease: monitoring of circulating immune complexes.
    Salo E; Kekomäki R; Pelkonen P; Ruuskanen O; Viander M; Wagner O
    Eur J Pediatr; 1988 May; 147(4):377-80. PubMed ID: 3294012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating immune complexes in Indian childhood cirrhosis.
    Kalra V; Harkiss GD; Lachmann PJ; Ghai OP
    Clin Exp Immunol; 1982 Oct; 50(1):1-6. PubMed ID: 6924609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum oxidant/antioxidant status in patients with Behçet's disease.
    Taysi S; Kocer I; Memisogullari R; Kiziltunc A
    Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
    Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circulating immune complex and complement (C3) in a course of pulmonary tuberculosis].
    Dubaniewicz A; Sztaba-Kania M
    Pol Merkur Lekarski; 2002 Jun; 12(72):491-5. PubMed ID: 12362668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immune complexes and C3 and C4 of the complement in urine of patients with glomerulonephritis].
    Kacprzyk F; Chrzanowski W
    Pol Arch Med Wewn; 1996 Sep; 96(3):215-23. PubMed ID: 9122012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of complement activating circulating immune complexes and an example for antigen specific immune complex assays.
    Krapf F; Fuchs C; Herrmann M; Hoferichter S; Kalden JR
    J Clin Lab Immunol; 1986 Dec; 21(4):183-7. PubMed ID: 3550093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
    Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
    PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
    Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
    J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
    Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
    Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum beta 2-microglobulin reflects disease activity in Behçet's disease.
    Aygündüz M; Bavbek N; Oztürk M; Kaftan O; Koşar A; Kirazli S
    Rheumatol Int; 2002 May; 22(1):5-8. PubMed ID: 12120912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of C3 & C4 levels with filarial immune complexes in bancroftian filariasis.
    Prasad GB; Harinath BC
    Indian J Med Res; 1989 Sep; 89():322-5. PubMed ID: 2697689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity.
    Turan B; Gallati H; Erdi H; Gürler A; Michel BA; Villiger PM
    J Rheumatol; 1997 Jan; 24(1):128-32. PubMed ID: 9002023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.
    Duygulu F; Evereklioglu C; Calis M; Borlu M; Cekmen M; Ascioglu O
    Clin Rheumatol; 2005 Aug; 24(4):324-30. PubMed ID: 15902528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
    Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
    Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.